Medicare beneficiaries could save more than $1 billion in copayments on prescription drugs in 2027 under new drug pricing guidelines proposed by the federal government on July 2.
The proposed rules would significantly narrow a loophole allowing major hospital chains to cash in on mandatory prescription drug discounts intended for struggling, safety-net providers.
The provision is part of the 340B Drug Pricing Program, which Congress created to assist providers such as underfunded rural hospitals and sole community hospitals.
Thanks to the widespread consolidation of hospitals, surgery centers, and physician practices, large healthcare corporations have been able to use these discounts to generate revenue from the resale of prescription drugs….
Feds Aim to Tighten Drug Payment Loophole, Save Taxpayers Billions
